share_log

津药药业(600488.SH):签订《股权托管协议》

Tianjin Tianyao Pharmaceuticals (600488.SH): Signed the "Equity Custody Agreement".

Gelonghui Finance ·  Jan 6 23:45

On January 7, Gronghui reported that Tianjin Tianyao Pharmaceuticals (600488.SH) announced that after approval by the company's ninth Board of Directors at the thirteenth meeting, to avoid potential competition issues with Innovent Biologics in the future, and since Innovent Biologics does not currently meet the conditions for injection into the listed company based on its Financial Indicators and Operation status, the company signed an "Equity Custody Agreement" with its affiliated party Tianyan Biotechnology, entrusting the management of the 55.5222% equity of Innovent Biologics owned by Tianyan Biotechnology, with the custody period from January 7, 2025, to January 6, 2028.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment